TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Surgeon comfort evaluation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Heart rate responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-reported anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoactivation in the ventromedial prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adjusted mean QALYs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mothers' use of emotion-based food to soothe
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bacterial counts in the root canal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of bacterial death on the surface of the biofilm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SpO2 (Peripheral Oxygenation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: D95% dose received by the CTV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum dose D2cc for rectum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum dose D2cc for bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Assessment of physical features in the birthing room
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Receipt of prescriptions for opioids within 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: Receipt of prescriptions for non-opioid pain medications within 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of postoperative vitreous hemorrhage (VH)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of unplanned pars plana vitrectomy (PPV)
Endpoint domain: Adverse events/effects
Primary endpoint: platelet consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total agreement scores for shoulder pathology assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: centre of pressure parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in incontinence symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with procedures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: linoleic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: n-6PUFA:n-3PUFA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: eicosapentaenoic acid (EPA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Swelling score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with at least one ocular manifestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to wearing the Fitbit
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean minutes of Fitbit-measured MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated brain tissue oxygen tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference of HbA1C from baseline to six months post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Unaided removal success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of donning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: siVaw increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: siRaw reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: post-dose FEV1 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Breath hydrogen production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Available energy per gram of fiber
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: oxygen uptake kinetic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expression of miR‐155 and miR‐181b
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of BAC detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increment of pain as measured by visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attrition at 3 and 6 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total analgesic usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median number of A-OXY pills used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median number of IBU pills used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative analgesic satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Same-day discharge
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: incremental quality-adjusted life-years (QALYs)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Platelet cell morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fiber architecture in fibrin membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDE duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDEs experienced
Endpoint domain: Adverse events/effects
Primary endpoint: early postoperative cognitive scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Alterations in metabolic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Major Adverse Cardiac Effect (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Instrumental Activity Daily Living (IADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: modulus of elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SA (Satisfaction Assessment)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mental health of healthcare professionals
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RT-induced local skin toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: TLco change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: TLC change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MSES scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose increase over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: adverse outcomes (mortality and readmission)
Endpoint domain: Mortality/survival
Primary endpoint: Dual-task costs to standing and walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Power Output (PO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of PPCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement of movement in the vertebral column
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Direct-to-ED referral rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pulse oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Support for the use of cannabinoids for symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PCA consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary function (FEV1, PEF, FEV1/FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: knee anteroposterior laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: femoral rollback
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: noise generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diabetic peripheral neuropathic pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sleep problems
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Days to start of appropriate anti-TB treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Culture conversion after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ENT residents' performance in a simulated bad-news consultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average daily metabolic equivalents (METs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: activity energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive rate of EBUS brushing and biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Expense during diagnosis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area Under the Curve (AUC) of vitamin D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cost savings
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in mean micturitions/24h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incontinence normalization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good clinical outcomes at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower DASH score at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disappearance of calcification at 3 and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggregate global assessment scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of steps completed correctly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of instruments improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increase in plasma DHA/AA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in plasma EPA/AA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hippocampal volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ADL accomplishment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: better diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune responses (geometric mean titers and concentrations)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Self‐Rating Anxiety Scale (SAS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self‐Rating Depression Scale (SDS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BMI at 12 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form 36 physical component summary
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lack of requirement for prednisone
Endpoint domain: Adverse events/effects
Primary endpoint: Overall treatment costs
Endpoint domain: Resource use
Primary endpoint: Perceived stress scale (PSS) values
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative lymph node metastasis prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of CGRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of ERK1 mRNA and ERK2 mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal composite outcome (eGFR reduction of ≥50%, end-stage renal disease, or death attributable to renal causes)
Endpoint domain: Adverse events/effects
Primary endpoint: Resilience (CD-RISC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive performance (MoCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (CQLS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: TA:GCM balance ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle DF range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TA muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean SpO2 differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rebleeding events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Human milk volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Macronutrient content of human milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Opioid consumption after discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Days on opioids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: New persistent opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of suicidal ideation
Endpoint domain: Adverse events/effects
Primary endpoint: plasma triglyceride incremental AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Best corrected visual acuity at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative complications in the first 3 months
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Vref increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean Fref increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean ABV drop reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Pressure Injury (PI) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCID in Patient Global Assessment (PtGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Survival time in months
Endpoint domain: Mortality/survival
Primary endpoint: Overactive Bladder Questionnaire‐Short Form quality of life survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: International Consultation on Incontinence Questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to undergo the procedure again
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in clinical parameters (CP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mechanical detection thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to pre-eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: postoperative 3-year mortality
Endpoint domain: Mortality/survival
Primary endpoint: Total correct steps achievements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with at least 1 critical error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of counseling attempts needed to reach correct handling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bleeding occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery of serum LH and FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Intentions to seek counselling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: GCS score progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematoma expansion control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow outcome scale-extended (GOSE)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cervical spine ASspiMRI‐c score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic Gait Index change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean measured energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical and biological complications rates
Endpoint domain: Adverse events/effects
Primary endpoint: Gastric Motility Index (GMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Amplitude of peristaltic waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Primary cardiovascular disease (CVD) outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major coronary heart disease (CHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in MAS wrist score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability Assessment Scale score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Investigator's Clinical Global Impression score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of fetal growth restriction and perinatal death
Endpoint domain: Mortality/survival
Primary endpoint: Total morphine consumption at 24 h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of severe complications (grade 3-4)
Endpoint domain: Adverse events/effects
Primary endpoint: average exercise time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Susceptibility to infections of the respiratory tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Occurrence of rhinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: improvements in depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pore tightening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Attentional bias to drug-related clues
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 10-year disease recurrence (DR) risk
Endpoint domain: Mortality/survival
Primary endpoint: ADL capacity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of active transport to or from school
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Corticospinal excitability of M1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PD AAO reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-exercise Tre
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of rise of Tre
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CVI change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Score (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peak Urinary Flow Rate (Qmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Glucocorticoid initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion achieving target blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma concentrations of P1NP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: loss of adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: loss of lean tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pediatric Anesthesia Emergence Delirium scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' well-being scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing